Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BTX-10504
- Development stage
- Unknown
- Lead developer
- BioTheryX
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
BTX-10504 is an oral aqueous suspension formulation of ciclopirox, a synthetic hydroxypyridone antifungal agent that has been repurposed by BioTheryX for the treatment of hematologic malignancies, including acute myeloid leukemia (AML), multiple myeloma, and myelodysplastic syndromes. Preclinical and early clinical development focused on exploiting ciclopirox’s ability to disrupt key survival pathways in malignant cells—such as iron-dependent and cell-cycle–related processes—leading to growth inhibition and apoptosis in leukemic and myeloma cells. BioTheryX advanced BTX-10504 into a phase 1 clinical trial in blood cancers with support from The Leukemia & Lymphoma Society, but no active development has been reported in recent years, and the program appears to have stalled at early clinical stages.[3][5][7]
- Other names
- Ciclopirox oralCiclopirox olamine
Beyond the preview
Go deeper on BTX-10504.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BTX-10504.